IL-4 regulation of p38 MAPK signalling is dependent on cell type

被引:30
作者
Hunt, AE [1 ]
Williams, LM [1 ]
Lali, FV [1 ]
Foxwell, BMJ [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Kennedy Inst Rheumatol, London W6 8LH, England
基金
英国惠康基金;
关键词
B-cells; interleukin-4; monocytes; p38; MAPK; T cells;
D O I
10.1006/cyto.2002.1043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p38 MAPK was originally characterized as a stress-induced kinase, along with JNK. Subsequently, p38 MAPK was found to be activated by stimuli other than cellular stress, such as growth factors and mitogens, like interleukin (IL)-2, IL-7 and IL-3. A notable exception was IL-4, as studies in mast cells showed no activation of p38 MAPK by this cytokine. In this study we show that the regulation of p38 MAPK is cell type dependent. Like other cytokines that signal through the gamma (gamma)(c), IL-4 can activate p38 MAPK in the CT6 T-cell line and BA/F3 pro-B-cells. However, IL-4 was unable to activate p38 MAPK in the murine macrophage cell line, RAW 264.7 and, indeed, prolonged exposure of cells to IL-4 results in suppression of LPS-induced MAPK activation. This result correlates with the well defined inhibitory effect of IL-4 on tumour necrosis factor alpha (TNFalpha) production. In contrast, studies in primary human monocytes showed that prolonged exposure to IL-4 resulted in enhanced activation of LPS-stimulated p38 MAPK; this correlated with an enhanced TNFalpha production. These data highlight the complexity of IL-4 signalling mechanisms, the diversity that can exist in the regulation of a given signalling pathway by a given cytokine and, furthermore, indicate the problems that can arise from extrapolation between different cell systems. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:295 / 303
页数:9
相关论文
共 44 条
[1]  
Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486
[2]  
Clarke CJP, 1998, EUR J IMMUNOL, V28, P1719, DOI 10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO
[3]  
2-Q
[4]   Interleukin-7 induces T cell proliferation in the absence of ErK/MAP kinase activity [J].
Crawley, JB ;
Willcocks, J ;
Foxwell, BMJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (11) :2717-2723
[5]   T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation [J].
Crawley, JB ;
Rawlinson, L ;
Lali, FV ;
Page, TH ;
Saklatvala, J ;
Foxwell, BMJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) :15023-15027
[6]   STIMULATORY AND INHIBITORY EFFECTS OF INTERLEUKIN (IL)-4 AND IL-13 ON THE PRODUCTION OF CYTOKINES BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRIMING FOR IL-12 AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION [J].
DANDREA, A ;
MA, XJ ;
ASTEAMEZAGA, M ;
PAGANIN, C ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :537-546
[7]  
ESSNER R, 1989, J IMMUNOL, V142, P3857
[8]  
FAIRHURST RM, 1993, IMMUNOLOGY, V79, P112
[9]  
Foey AD, 1998, J IMMUNOL, V160, P920
[10]   Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4 [J].
Foltz, IN ;
Schrader, JW .
BLOOD, 1997, 89 (09) :3092-3096